Table 2 Unadjusted estimates of each outcome for entire cohort by initial treatment group
| Â | No cancer-directed therapy | Radiation | Chemotherapy | Surgery alone | Surgery and chemotherapy | Total |
|---|---|---|---|---|---|---|
N = 5551 | N = 461 | N = 2677 | N = 692 | N = 569 | N = 9950 | |
Survival, median days from diagnosis (IQR) | 47 (22–107) | 120 (64–218) | 224 (122–373) | 326 (158–559) | 494 (304–746) | 105 (37–277) |
Healthcare encounters per 30 days, median (IQR) | 9 (5–18) | 7 (4–13) | 5 (3–8) | 4 (2–7) | 4 (3–7) | 7 (4–12) |
Palliative care visits per 30 days, median (IQR) | 1 (0–6) | 1 (0–6) | 0 (0–4) | 0 (0–3) | 0 (0–4) | 1 (0–5) |
Institutional deatha, n (%) | 3557 (64%) | 263 (57%) | 1425 (53%) | 400 (56%) | 295 (52%) | 5940 (60%) |
Hospitalization within last 30 days of life, n (%) | 3347 (60%) | 234 (51%) | 1457 (54%) | 342 (49%) | 285 (50%) | 5665 (57%) |
Chemotherapy within last 30 days of life, n (%) | 33 (1%) | 11 (2%) | 722 (27%) | 41 (6%) | 68 (12%) | 875 (9%) |